HeimLH • NYSE
add
Labcorp Holdings Inc
239,67 $
Eftir lokun(0,00%)0,00
239,67 $
Lokað: 22. nóv., 16:30:01 GMT-5 · USD · NYSE · Lagalegir fyrirvarar
Við síðustu lokun
240,17 $
Dagbil
238,82 $ - 240,97 $
Árabil
191,97 $ - 247,99 $
Markaðsvirði
20,05 ma. USD
Meðalmagn
702,29 þ.
V/H-hlutf.
46,45
A/V-hlutfall
1,20%
Aðalkauphöll
NYSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD) | sep. 2024info | Breyting á/á |
---|---|---|
Tekjur | 3,28 ma. | 7,37% |
Rekstrarkostnaður | 632,30 m. | 8,79% |
Nettótekjur | 169,30 m. | -7,64% |
Hagnaðarhlutfall | 5,16 | -14,00% |
Hagnaður á hvern hlut | 3,50 | 3,55% |
EBITDA | 433,60 m. | 4,26% |
Virkt skatthlutfall | 19,47% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(USD) | sep. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 1,52 ma. | 108,45% |
Heildareignir | 18,61 ma. | 10,22% |
Heildarskuldir | 10,43 ma. | 15,94% |
Eigið fé alls | 8,19 ma. | — |
Útistandandi hlutabréf | 83,64 m. | — |
Eiginfjárgengi | 2,46 | — |
Arðsemi eigna | 3,85% | — |
Ávöxtun eigin fjár | 4,53% | — |
Peningaflæði
Breyting á handbæru fé
(USD) | sep. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 169,30 m. | -7,64% |
Handbært fé frá rekstri | 277,30 m. | -27,96% |
Reiðufé frá fjárfestingum | -579,10 m. | -18,77% |
Reiðufé frá fjármögnun | 1,55 ma. | 241,11% |
Breyting á handbæru fé | 1,25 ma. | 204,12% |
Frjálst peningaflæði | 62,96 m. | -61,33% |
Um
Laboratory Corporation of America Holdings, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of the division's revenue are from Medicare.
Its Biopharma Laboratory Services segment provides drug development, medical device and diagnostic development services to pharmaceutical, biotechnology, medical device, and diagnostic companies. Wikipedia
Framkvæmdastjóri
Stofnsett
1978
Höfuðstöðvar
Vefsvæði
Starfsfólk
61.975